The effect of rosmarinic acid on 1,2-dimethylhydrazine induced colon carcinogenesis. 2013

Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar 608002, Tamilnadu, India.

This study was carried out to investigate the chemopreventive potential of rosmarinic acid (RA) against 1,2-dimethylhydrazine (DMH) induced rat colon carcinogenesis by evaluating the effect of RA on tumour formation, antioxidant enzymes, cytochrome P450 content, p-nitrophenol hydroxylase and GST activities. Rats were divided into six groups and fed modified pellet diet for the entire experimental period. Group 1 served as control, group 2 received RA (10 mg/kgb.w.). Groups 3-6 were induced colon cancer by injecting DMH (20 mg/kgb.w.) subcutaneously once a week for the first four weeks (groups 3-6). In addition, RA was administered at the doses of 2.5, 5 and 10 mg/kgb.w. to groups 4-6 respectively. DMH treated rats showed large number of colonic tumours; decreased lipid peroxidation; decreased antioxidant status; elevated CYP450 content and PNPH activities; and decreased GST activity in the liver and colon. Supplementation with RA (5 mgkg/b.w.) to DMH treated rats significantly decreased the number of polyps (50%); reversed the markers of oxidative stress (21.0%); antioxidant status (38.55%); CYP450 content (29.41%); and PNPH activities (21.9%). RA at the dose of 5 mg/kgb.w. showed a most pronounced effect and could be used as a possible chemopreventive agent against colon cancer.

UI MeSH Term Description Entries
D008297 Male Males
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002934 Cinnamates Derivatives of cinnamic acid (the structural formula: phenyl-HC Cinnamate
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000097123 Rosmarinic Acid A polyphenol compound that naturally occurs in rosemary with ANTIOXIDANT and anti-inflammatory properties. Rosemary Acid,Rosmarinate,Rosmarinic Acid, (R-(E))-Isomer,Acid, Rosemary,Acid, Rosmarinic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
January 1984, IARC scientific publications,
Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
January 2011, Journal of experimental therapeutics & oncology,
Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
December 2014, Human & experimental toxicology,
Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
November 2012, Environmental toxicology and pharmacology,
Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
January 2016, Journal of cancer research and therapeutics,
Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
January 1997, Anticancer research,
Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
April 1983, Cancer research,
Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
January 2017, Journal of advanced pharmaceutical technology & research,
Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
January 2006, Journal of medicinal food,
Karthikkumar Venkatachalam, and Sivagami Gunasekaran, and Victor Antony Santiago Jesudoss, and Nalini Namasivayam
October 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
Copied contents to your clipboard!